Efficacy of intravenous administration of magnesium and pottasium solution in cardioversion of postoperative atrial fibrillatio

Phase 3

Recruiting

• Conditions: Postoperative atrial fibrillation.; Other postprocedural complications and disorders of the circulatory system, not elsewhere classified; I97.89

• Registration Number: IRCT20180430039488N2
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 May 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 360

Inclusion Criteria

Atrial fibrillation after isolated coronary artery bypass graft surgery
Continuation of atrial fibrillation rhythm for at least 15 minutes after initiation
Serum Potassium level of 4-4.5 meq/L
Serum Magnesium level of 4-4.5 meq/L
Informed consent to participate in the study

Exclusion Criteria

Unstable hemodynamic (systolic blood pressure less than 90 mmHg)
History of atrial fibrillation (persistent or paroxysmal) before surgery
Serum creatinine level more than 1.4 mg/dl
More than 12 hours have passed since the beginning of the atrial fibrillation rhythm
Patients receiving packed cell
Hemoglobin level less than 7 g/L
Spontaneous cardioversion before randomization
Patients receiving Inotrope

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cardioversion of atrial fibrillation to sinus rhythm within the first 6 hour. Timepoint: From the start of the intervention until 6 hours later. Method of measurement: Cardiac rhythm monitoring.